Schonfeld Strategic Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$974K Sell
3,297
-59,902
-95% -$17.8M 0.01% 1110
2025
Q4
$17.3M Buy
63,199
+60,033
+1,896% +$16.3M 0.08% 227
2025
Q3
$855K Sell
3,166
-44,387
-93% -$12.1M ﹤0.01% 1459
2025
Q2
$13.1M Buy
47,553
+22,871
+93% +$6.22M 0.09% 261
2025
Q1
$6.55M Buy
24,682
+7,281
+42% +$1.8M 0.04% 447
2024
Q4
$4.04M Sell
17,401
-47,109
-73% -$10.8M 0.02% 570
2024
Q3
$14.2M Buy
64,510
+35,164
+120% +$7.28M 0.1% 219
2024
Q2
$5.77M Buy
29,346
+19,354
+194% +$4M 0.04% 508
2024
Q1
$2.15M Sell
9,992
-107,975
-92% -$22.7M 0.01% 972
2023
Q4
$24.8M Buy
117,967
+42,749
+57% +$9.12M 0.16% 123
2023
Q3
$15.1M Sell
75,218
-27,782
-27% -$5.52M 0.12% 245
2023
Q2
$19.1M Sell
103,000
-49,205
-32% -$9.09M 0.16% 186
2023
Q1
$29.2M Sell
152,205
-24,095
-14% -$4.36M 0.28% 91
2022
Q4
$29.6M Sell
176,300
-123,736
-41% -$21.5M 0.25% 99
2022
Q3
$53.1M Buy
300,036
+222,318
+286% +$43.9M 0.44% 23
2022
Q2
$15.9M Sell
77,718
-87,635
-53% -$18.6M 0.15% 178
2022
Q1
$39.3M Sell
165,353
-200,472
-55% -$47.1M 0.35% 38
2021
Q4
$83.6M Buy
365,825
+253,701
+226% +$55.8M 0.76% 11
2021
Q3
$21.7M Buy
112,124
+52,124
+87% +$10.6M 0.22% 104
2021
Q2
$12.8M Sell
60,000
-36,673
-38% -$7.74M 0.14% 229
2021
Q1
$19.7M Buy
96,673
+31,973
+49% +$6.3M 0.24% 97
2020
Q4
$11.8M Sell
64,700
-31,486
-33% -$5.35M 0.16% 175
2020
Q3
$16.1M Sell
96,186
-47,571
-33% -$8.01M 0.31% 67
2020
Q2
$23.4M Buy
143,757
+83,757
+140% +$15M 0.6% 20
2020
Q1
$10.4M Hold
60,000
0.65% 19
2019
Q4
$12M Sell
60,000
-137,588
-70% -$28.2M 0.29% 89
2019
Q3
$41.8M Sell
197,588
-36,627
-16% -$7.65M 1.23% 7
2019
Q2
$33.8M Buy
234,215
+33,615
+17% +$6.2M 1.2% 7
2019
Q1
$33M Buy
200,600
+140,600
+234% +$24.9M 1.15% 4
2018
Q4
$11.3M Hold
60,000
0.43% 49
2018
Q3
$10.2M Sell
60,000
-10,797
-15% -$1.82M 0.45% 41
2018
Q2
$11.6M Sell
70,797
-25,124
-26% -$4.1M 0.63% 14
2018
Q1
$15.5M Buy
95,921
+43,220
+82% +$6.88M 1.16% 4
2017
Q4
$7.71M Sell
52,701
-11,255
-18% -$1.6M 0.63% 27
2017
Q3
$8.68M Buy
63,956
+12,956
+25% +$1.64M 0.79% 17
2017
Q2
$6.39M Buy
51,000
+41,911
+461% +$5.01M 0.66% 25
2017
Q1
$1.08M Buy
9,089
+3,886
+75% +$467K 0.11% 244
2016
Q4
$600K Sell
5,203
-5,093
-49% -$567K 0.08% 304
2016
Q3
$1.08M Sell
10,296
-8,931
-46% -$932K 0.18% 158
2016
Q2
$1.87M Buy
+19,227
New +$1.82M 0.42% 56

Other funds holding CME

Schonfeld Strategic Advisors's CME Position: Q1 2026 in Review

Schonfeld Strategic Advisors reduced its CME Group (CME) stake by 95% in Q1 2026, selling an estimated $17.8M and leaving 3,297 shares worth $974K. The position accounts for 0.01% of the portfolio, ranked #1110.

Schonfeld Strategic Advisors first reported a position in CME in Q2 2016 and has held it in 40 quarters since. The position peaked at $83.6M in Q4 2021. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Schonfeld Strategic Advisors held 3,297 shares of CME Group worth $974K as of Q1 2026.
  • Schonfeld Strategic Advisors sold 59,902 CME Group shares in Q1 2026, an estimated $17.8M.
  • CME Group made up 0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #1110 holding.
  • Schonfeld Strategic Advisors first reported a position in CME Group in Q2 2016 and has held it in 40 quarters since.
  • Schonfeld Strategic Advisors's CME Group position peaked at $83.6M in Q4 2021.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.